- NVRO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
SD Filing
Nevro (NVRO) SDConflict minerals disclosure
Filed: 23 May 23, 5:04pm
Exhibit 1.01 to Form SD
Nevro Corp. Conflict Minerals Report
For the Period from January 1, 2022 to December 31, 2022
This Conflict Minerals Report is filed in accordance with Rule 13p-l and the Form SD, as required by the Securities Exchange Act of 1934, as amended, for the reporting period of January 1, 2022 to December 31, 2022 (“Reporting Period”).
Nevro Corp. and Covered Product Overview
Nevro Corp. (“Nevro”) is a publicly-traded medical device company, headquartered in Redwood City, California. Nevro has developed and commercialized the Senza® spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. We have commercialized four different generations within the Senza family of products – Senza I, Senza II, Senza Omnia and Senza HFX iQ system (collectively, the “Covered Products”).
Nevro Corp. is listed on the New York Stock Exchange and is therefore subject to final rules issued by the United State Securities and Exchange Commission (“SEC”) and Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act (“Dodd-Frank Act”).
Nevro's Reasonable Country of Origin Inquiry Process
In preparation of filing a Form SD, Nevro conducted, in good faith, a reasonable country of origin inquiry (“RCOI”) regarding the tantalum, tungsten, tin, and gold (“3TG Minerals”) used in each component of its Covered Products. Nevro undertook its RCOI effort to determine whether any of the 3TG Minerals used in its Covered Products originated in the Democratic Republic of Congo or any of its nine adjoining countries (“Covered Countries”). Nevro sent its suppliers an RCOI letter explaining Nevro's obligations under Rule 13p-1 and requested that the recipient suppliers complete and return a Conflict Minerals Report Template (“CMRT”), as developed and published by the Responsible Minerals Initiative (“RMI”) Responsible Minerals Assurance Program (“RMAP”). Nevro tracked, reviewed, and analyzed supplier responses to its RCOI requests.
Nevro's Due Diligence Process
Nevro exercised due diligence in determining the source and chain of custody of the 3TG Minerals used in the manufacture of its Covered Products, in line with the OECD Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas (“OECD Guidance”):
Future Due Diligence Measures
Since Nevro does not directly source the minerals necessary to the functionality or production of its Covered Product, Nevro will continue to rely on its suppliers to provide information regarding the source and chain of custody of such 3TG Minerals. Nevro will:
Based on Nevro's due diligence efforts to date:
Through our participation in the RMI, due diligence in line with the OECD framework and requesting our suppliers to complete the CMRT, we have determined that seeking information about 3TG smelters or refiners in our supply chain from our suppliers represents the most commercially reasonable effort we can make to determine the mines or locations of origin of the 3TG in our supply chain.
Based on the information collected from our suppliers, we have concluded that most of the Conflict Minerals included in our Covered Products have been sourced from outside the Covered Countries. However, for some of the Conflict Minerals contained in our Covered Products, we have insufficient information from suppliers and other sources regarding the smelters and refiners that processed the Conflict Minerals and the related name and location of the mines used to conclude whether they originated in the Covered Countries and, if they did, whether those Conflict Minerals were from recycled or scrap sources, or other conflict free sources.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
2